Alembic Pharmaceuticals informs about press release

11 May 2022 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Arformoterol Tartrate Inhalation Solution, 15 mcg (base)/2 ml Unit-dose Vial. In this regard, the company has enclosed a press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

757.30 -13.55 (-1.76%)
24-Feb-2026 12:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1737.80
Dr. Reddys Lab 1304.35
Cipla 1327.10
Zydus Lifesciences 905.15
Lupin 2245.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×